NEW YORK (GenomeWeb) – The Stanley Center at the Broad Institute has received a promise of $650 million from philanthropist Ted Stanley to fund genomic research of psychiatric disorders in order to eventually identify and develop molecularly targeted drugs.

According to the Broad Institute, Stanley's new commitment to his namesake institute will consist of annual gifts during his lifetime followed by a bequest, totaling about $650 million. Taking prior gifts into account, Stanley's support of the Broad totals more than $825 million, the institute said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.